IRIDEX (IRIX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on IRIDEX (IRIX) is Moderate Underperform.

The composite score behind that read is -0.24, weighing +0.05 of bullish evidence against -0.33 bearish.

IRIDEX last closed at $0.69, +7.81% on the session.

Against the IVW growth benchmark the position is +6.89% over the forecast window.

The read is built from 11 underlying insights — 3 bullish and 8 bearish.

Agreement across those insights is 73%.

16 graded predictions for IRIX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks IRIDEX in the 98th percentile on return on equity, where 100 is best.

IRIDEX is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $11.30M.

StockMap tracks IRIDEX as the 125th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite IRIDEX ranks 78th of 133 in the group, against a group median of -0.21.